Pfizer will pay China’s 3SBio $1.25 billion upfront to gain access to a cancer therapy that could rival Akeso and Summit’s ...

The latecomer PD-1 inhibitor – already approved for Merkel cell carcinoma – has become the first cancer immunotherapy for advanced squamous cell carcinoma of the anal canal (SCAC), although ...

It is the second drug in the PD-1/PD-L1 inhibitor class to be cleared in a subcutaneous injection form by the FDA after Roche's Tecentriq Hybreza (atezolizumab and hyaluronidase) – which got a ...

Zynyz, first approved in 2023 for metastatic, recurrent or locally advanced Merkel cell carcinoma, is an intravenous PD-1 inhibitor that forms a substantial part of Incyte’s cancer portfolio. In an ...

Godrej Edge 190 lt is a good budget refrigerator (under 15k). It has 5 star rating and consumes less power - noticeable in last few months. It can be moved easily in kitchen or nearby area. There is ...

Leronlimab treatment was tied to an increased expression of an immune cell protein or “checkpoint inhibitor” known as programmed death-ligand 1 (“PD-L1”) on circulating tumor cells in patients with ...

Developer NetherRealm has surprise-launched a Definite Edition of 2023's divisive Mortal Kombat 1, and some fans are taking it as a sign that development is coming to an end. NetherRealm released ...

PS Plus Premium is slumping back into old habits. The top-tier subscription service, which arrived with the grand promise of cloud streaming and retro classics, had been on a bit of an upwards ...

Marc Benioff predicts that Microsoft's multi-billion-dollar partnership with OpenAI might be coming to a bitter end.